{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:17:56Z","timestamp":1770992276257,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11596-020-2202-4","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T09:02:44Z","timestamp":1590829364000},"page":"502-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationship between Methylation of FHIT and CDH13 Gene Promoter Region and Liver Cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Ao-dun","family":"Tuoya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-shu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-xia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu-ya","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-li","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-hou","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"issue":"6","key":"2202_CR1","doi-asserted-by":"crossref","first-page":"e015936","DOI":"10.1136\/bmjopen-2017-015936","volume":"7","author":"JK Chiang","year":"2017","unstructured":"Chiang JK, Chih WL, Kao YH. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open, 2017, 7(6):e015936","journal-title":"BMJ Open"},{"issue":"2","key":"2202_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CACancer J Clin, 2016, 66(2): 115\u2013132","journal-title":"CACancer J Clin"},{"issue":"3","key":"2202_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1534735415622011","volume":"15","author":"QB Zhang","year":"2016","unstructured":"Zhang QB, Meng XT, Jia QA, et al. Herbal compound songyou yin and moderate swimming suppress growth and metastasis of liver cancer by enhancing immune function. Integr Cancer Ther, 2016, 15(3): 368\u2013375","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"2202_CR4","first-page":"231","volume":"9","author":"AR Karpf","year":"2007","unstructured":"Karpf AR. Epigenomic reactivation screening to identify genes silenced by DNA hypermethylation in human cancer. Curr Opin Mol Ther, 2007, 9(3): 231\u2013241","journal-title":"Curr Opin Mol Ther"},{"issue":"5","key":"2202_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11596-019-2098-z","volume":"39","author":"QB Huang","year":"2019","unstructured":"Huang QB, Zhang HW, Liao ZB. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway. Curr Med Sci, 2019, 39(5): 727\u2013733","journal-title":"Curr Med Sci"},{"issue":"6","key":"2202_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11596-019-2123-2","volume":"39","author":"BB Zhao","year":"2019","unstructured":"Zhao BB, Ye ZH, Gao X, et al. Diwu Yanggan Modulates the Wnt\/p-catenin Pathway and Inhibits Liver Carcinogenesis Signaling in 2-AAF\/PH Model Rats. Curr Med Sci, 2019, 39(6): 913\u2013919","journal-title":"Curr Med Sci"},{"issue":"6","key":"2202_CR7","first-page":"1045","volume":"38","author":"Q Wang","year":"2018","unstructured":"Wang Q, Pan LH, Lin L, et al. Essential Oil from Carpesium abrotanoides L. Induces Apoptosis via Activating Mitochondrial Pathway in Hepatocellular Carcinoma Cells. Curr Med Sci, 2018, 38(6): 1045\u20131053","journal-title":"Induces Apoptosis via Activating Mitochondrial Pathway in Hepatocellular Carcinoma Cells. Curr Med Sci"},{"issue":"2","key":"2202_CR8","first-page":"1963","volume":"15","author":"Q Li","year":"2018","unstructured":"Li Q, Ding L, Jing N, et al. Folate deficiency and aberrant DNAmethylation and expression of FHIT gene were associated with cervical pathogenesis. Oncol Lett, 2018, 15(2): 1963\u20131972","journal-title":"Oncol Lett"},{"issue":"3","key":"2202_CR9","first-page":"504","volume":"57","author":"T Druck","year":"1997","unstructured":"Druck T, Hadaczek P, Fu TB, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res, 1997, 57(3): 504\u2013512","journal-title":"Cancer Res"},{"issue":"5","key":"2202_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4161\/epi.6.5.15237","volume":"6","author":"S Sirnes","year":"2011","unstructured":"Sirnes S, Honne H, Ahmed D, et al. DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (Connexin45) by promoter hypermethylation in colorectal cancer. Epigenetics, 2011, 6(5): 602\u2013609","journal-title":"Epigenetics"},{"key":"2202_CR11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.bjc.6602095","volume":"91","author":"K Hibi","year":"2004","unstructured":"Hibi K, Kodera Y, Ito K, et al. Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer, 2004, 91: 1139\u20131142","journal-title":"Br J Cancer"},{"key":"2202_CR12","first-page":"1572","volume":"20","author":"YL Lin","year":"2014","unstructured":"Lin YL, Xie PG, Ma JG. Aberrantmethylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer. Med Sci Momt, 2014, 20: 1572\u20131577","journal-title":"Med Sci Momt"},{"issue":"2","key":"2202_CR13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12032-011-9836-9","volume":"29","author":"JZ Ren","year":"2012","unstructured":"Ren JZ, Huo JR. Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells. Med Oncol, 2012, 29(2): 915\u2013918","journal-title":"Med Oncol"},{"issue":"2","key":"2202_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ijc.11706","volume":"109","author":"A Widschwendter","year":"2004","unstructured":"Widschwendter A, Ivarsson L, Blassnig A, et al. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer, 2004, 109(2): 163\u2013166","journal-title":"Int J Cancer"},{"issue":"5","key":"2202_CR15","doi-asserted-by":"crossref","first-page":"e0149185","DOI":"10.1371\/journal.pone.0149185","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Niu H, Huang Y, et al. A systematic analysis of the relationship of CDH13 promoter methylation and breast cancer risk and prognosis. PLoS One, 2016, 11(5):e0149185","journal-title":"PLoS One"},{"issue":"5","key":"2202_CR16","first-page":"1139","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhang L, Yang J, et al. CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells. Oncol Lett, 2018, 16(5): 1139\u20131143","journal-title":"Oncol Lett"},{"issue":"3","key":"2202_CR17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.7314\/APJCP.2015.16.3.1139","volume":"16","author":"YH Zhong","year":"2015","unstructured":"Zhong YH, Peng H, Cheng HZ, et al. Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer. Asian Pac J Cancer Prev, 2015, 16(3): 1139\u20131143","journal-title":"Asian Pac J Cancer Prev"},{"key":"2202_CR18","first-page":"13","volume-title":"Forensic DNA Typing Protocols. Methods in Molecular Biology","author":"S Kochl","year":"2005","unstructured":"Kochl S, Niederstatter H, Parson W. DNA extraction and quantitation of forensic samples using the phenol-chloroform method and real-time PCR. In: Carracedo A, ed. Forensic DNA Typing Protocols. Methods in Molecular Biology. Totowa, NJ, USA: Humana Press, 2005:13\u201329."},{"issue":"3","key":"2202_CR19","first-page":"3","volume":"19","author":"M Szumilas","year":"2010","unstructured":"Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry, 2010, 19(3): 3\u2013227","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"3","key":"2202_CR20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.alcohol.2005.04.004","volume":"35","author":"IH McKillop","year":"2005","unstructured":"McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol, 2005, 35(3): 195\u2013203","journal-title":"Alcohol"},{"issue":"10","key":"2202_CR21","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/1055-9965.EPI-10-0499","volume":"19","author":"JR Shanmugham","year":"2010","unstructured":"Shanmugham JR, Zavras Al, Rosner BA, et al. Alcohol-folate interactions in the risk of oral cancer in women: a prospective cohort study. Cancer Epidemiol Prev Biomarkers, 2010, 19(10): 2516\u20132524","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"6","key":"2202_CR22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyp280","volume":"38","author":"YCA Lee","year":"2009","unstructured":"Lee YCA, Cohet C, Yang YC, et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol, 2009, 38(6): 1497\u20131511","journal-title":"Int J Epidemiol"},{"issue":"39","key":"2202_CR23","first-page":"3","volume":"50","author":"JJ Qi","year":"2010","unstructured":"Qi JJ, Wen J, Zhang LY, et al. Correlation between diabetes and smoking index and benign prostatic hyperplasia. Shandong Med J (Chinese), 2010, 50(39): 3\u20135","journal-title":"Shandong Med J (Chinese)"},{"issue":"4","key":"2202_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)81034-X","volume":"84","author":"M Ohta","year":"1996","unstructured":"Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3pl4.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 1996, 84(4): 587\u2013597","journal-title":"Cell"},{"issue":"3","key":"2202_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0896-6273(91)90291-7","volume":"7","author":"B Ranscht","year":"1991","unstructured":"Ranscht B, Dours Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron, 1991, 7(3): 391\u2013402","journal-title":"Neuron"},{"issue":"7271","key":"2202_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 2009, 462(7271): 315\u2013322","journal-title":"Nature"},{"issue":"16","key":"2202_CR27","doi-asserted-by":"crossref","first-page":"e6650","DOI":"10.1097\/MD.0000000000006650","volume":"96","author":"C Zhu","year":"2017","unstructured":"Zhu C, Feng X, Ye G, et al. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline. Medicine, 2017, 96(16):e6650","journal-title":"Medicine"},{"key":"2202_CR28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A. DNA methylation patterns and epigenetic memory. Genes Dev, 2002, 16: 6\u201321","journal-title":"Genes Dev"},{"key":"2202_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60806-4","volume":"54","author":"PA Jones","year":"1990","unstructured":"Jones PA, Buckley JD. The role of DNA methylation in cancer. Adv Cancer Res, 1990, 54: 1\u201323","journal-title":"Adv Cancer Res"},{"issue":"9","key":"2202_CR30","first-page":"5439","volume":"2015","author":"Y Su","year":"2015","unstructured":"Su Y, Wang X, Li J, et al. The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review. Drug Des Devel Ther, 2015, 2015(9): 5439\u20135445","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"2202_CR31","first-page":"3724","volume":"63","author":"T Kuroki","year":"2003","unstructured":"Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res, 2003, 63(3): 3724\u20133728","journal-title":"Cancer Res"},{"issue":"9","key":"2202_CR32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/JTO.0000000000000256","volume":"9","author":"A Drilon","year":"2014","unstructured":"Drilon A, Sugita H, Sima CS, et al. A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol, 2014, 9(9): 1272\u20131277","journal-title":"J Thorac Oncol"},{"key":"2202_CR33","doi-asserted-by":"crossref","first-page":"e27889","DOI":"10.1371\/journal.pone.0027889","volume":"6","author":"K Konishi","year":"2011","unstructured":"Konishi K, Watanabe Y, Shen L, et al. DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis. PLoS One, 2011, 6:e27889","journal-title":"PLoS One"},{"key":"2202_CR34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/modpathol.2013.207","volume":"27","author":"CB Moelans","year":"2014","unstructured":"Moelans CB, de Groot JS, Pan X, et al. Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA. Mod Pathol, 2014, 27: 869\u2013874","journal-title":"Mod Pathol"},{"issue":"10","key":"2202_CR35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1158\/1940-6207.CAPR-13-0034","volume":"6","author":"T Tahara","year":"2013","unstructured":"Tahara T, Maegawa S, Chung W, et al. Examination of whole blood DNA methylation as a potential risk marker for gastric cancer. Cancer Prev Res (Phila), 2013, 6(10): 1093\u20131100","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"2202_CR36","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/ijc.23804","volume":"123","author":"Z Jin","year":"2008","unstructured":"Jin Z, Cheng Y, Olaru A, et al. Promoter hypermethylation of CDH13 is a common, early event inhuman esophageal adenocarcinogenesis and correlates with clinical risk factors. Int J Cancer, 2008, 123(10) 2331\u20132336","journal-title":"Int J Cancer"},{"key":"2202_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12894-016-0171-5","volume":"16","author":"F Chen","year":"2016","unstructured":"Chen F, Huang T, Ren Y, et al. Clinical significance of CDH 13 promoter methylation as a biomarker for bladder cancer: a meta-analysis. BMC Urol, 2016, 16:52","journal-title":"BMC Urol"},{"issue":"4","key":"2202_CR38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1023905900171","volume":"14","author":"YC Chen","year":"2003","unstructured":"Chen YC. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control, 2003, 14(4): 303\u2013310","journal-title":"Cancer Causes Control"},{"issue":"22","key":"2202_CR39","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1158\/1078-0432.CCR-04-0930","volume":"10","author":"MG Friedrich","year":"2004","unstructured":"Friedrich MG. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res, 2004, 10(22): 7457\u20137465","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2202_CR40","first-page":"8659","volume":"61","author":"R Maruyama","year":"2001","unstructured":"Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res, 2001, 61(24): 8659\u20138663","journal-title":"Cancer Res"},{"key":"2202_CR41","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s10856-010-4161-y","volume":"21","author":"H Zhang","year":"2015","unstructured":"Zhang H, Nie W, Huang F. The correlation relationship between P14ARF gene DNA methylation and primary liver cancer. Med Sci Momt, 2015, 21: 3077\u20133082","journal-title":"Med Sci Momt"},{"key":"2202_CR42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/sj.bjc.6601647","volume":"90","author":"K Hibi","year":"2004","unstructured":"Hibi K, Nakayama H, Kodera Y, et al. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer, 2004, 90: 1030\u20131033","journal-title":"Br J Cancer"},{"issue":"7","key":"2202_CR43","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cncr.20144","volume":"100","author":"R Maruyama","year":"2004","unstructured":"Maruyama R, Sugio K, Yoshino I, et al. Hypermethylation of FHIT as a prognostic marker in non-small cell lung carcinoma. Cancer, 2004, 100(7): 1472\u20131477","journal-title":"Cancer"},{"issue":"9","key":"2202_CR44","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","volume":"122","author":"AB Ryerson","year":"2016","unstructured":"Ryerson AB, Eheman CR, Altekruse SF, et al. Annual report to the nation on the status of cancer, 1975\u20132012, featuring the increasing incidence of liver cancer. Cancer, 2016, 122(9): 1312\u20131337","journal-title":"Cancer"},{"key":"2202_CR45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/1471-2458-10-730","volume":"10","author":"H Liang","year":"2010","unstructured":"Liang H, Wang J, Xiao H, et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Pub Health, 2010, 10:730","journal-title":"BMC Pub Health"},{"issue":"6","key":"2202_CR46","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.7150\/jca.18169","volume":"8","author":"Z Lin","year":"2017","unstructured":"Lin Z, Luo M, Chen X, et al. Combined detection of plasma ZIC1, HOXD10 and RUNX3 methylation is a promising strategy for early detection of gastric cancer and precancerous lesions. J Cancer, 2017, 8(6): 1038\u20131044","journal-title":"J Cancer"},{"issue":"1","key":"2202_CR47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.a.20402","volume":"124","author":"R Klootwijk","year":"2004","unstructured":"Klootwijk R, Groenen P, Schijvenaars M, et al. Genetic variants in ZIC1, ZIC2, and ZIC3 are not major risk factors for neural tube defects in humans. Am J Med Genet A, 2004, 124(1):40\u201347","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2202_CR48","first-page":"1","volume":"231","author":"V Shah","year":"2004","unstructured":"Shah V, Drill E, Lance-Jones C. Ectopic expression of HoxdlO in thoracic spinal segments induces motoneurons with a lumbosacral molecular profile and axon projections to the limb. DevDyn, 2004, 231(1): 1\u201343","journal-title":"DevDyn"},{"issue":"7","key":"2202_CR49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ar.a.20339","volume":"288","author":"H Yamamoto","year":"2006","unstructured":"Yamamoto H, Ito K, Kawai M, et al. Runx3 expression during mouse tongue and palate development. Anat Rec A Discov Mol Cell Evol Biol, 2006, 288(7): 695\u2013699","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"issue":"17","key":"2202_CR50","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.7150\/jca.21368","volume":"8","author":"C Zhang","year":"2017","unstructured":"Zhang C, Yu W, Wang L, et al. DNA methylation analysis of the SHOX2 and RASSF1A panel m bronchoalveolar lavage fluid for lung cancer diagnosis. J Cancer, 2017, 8(17): 3585\u20133591","journal-title":"J Cancer"},{"issue":"5","key":"2202_CR51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11596-019-2103-6","volume":"39","author":"ZZ Zhu","year":"2019","unstructured":"Zhu ZZ, Bao LL, Zhao K, et al. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma. Curr Med Sci, 2019, 39(5): 759\u2013765","journal-title":"Curr Med Sci"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-020-2202-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T23:09:36Z","timestamp":1622329776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-020-2202-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2202"],"URL":"https:\/\/doi.org\/10.1007\/s11596-020-2202-4","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Inner Mongolia Medical University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}